George Manos, PhD
- 3Articles
- 12.3KReads
- 2011–2012Active
- 18Collaborators
- 356Citations
About
George Manos, PhD, has published research focused on the use of aripiprazole in various clinical contexts, including its safety and tolerability in pediatric patients with autistic disorder and irritability. His work also addresses adjunctive treatment effects of aripiprazole in major depressive disorder, examining factors such as antidepressant therapy history. His publications span topics in schizophrenia, schizoaffective disorders, depression, and neurology.
Publications
Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials
November 22, 2012
Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder in Pediatric Subjects (6-17 Years Old): Results From a Pooled Analysis of 2 Studies
January 6, 2011
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
